Therapeutic Efficacy of 177Lu-labeled h11B6 in Prostate Cancer Xenografts

被引：0
|
作者：
Timmermand, O. Vilhelmsson [1 ]
Elggvist, J. [1 ]
Akesson, A. [1 ]
Strand, S. [1 ]
Tran, T. A. [2 ]
机构：
[1] Lund Univ, Lund, Sweden
[2] Lund Univ, Bioimaging Ctr, Lund, Sweden
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP552
引用
收藏
页码：S280 / S280
页数：1
相关论文
共 50 条
  • [1] In vivo evaluation of 177Lu-labeled h11B6, a humanized antibody for hK2 targeting in prostate cancer
    Timmermand, Oskar Vilhelmsson
    Larsson, Erik
    Strand, Sven-Erik
    Thuy Tran
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [2] Therapeutic Efficacy of 177Lu-Labeled A20FMDV2 Peptides Targeting ανβ6
    Huynh, Truc Thao
    Sreekumar, Sreeja
    Mpoy, Cedric
    Rogers, Buck Edward
    PHARMACEUTICALS, 2022, 15 (02)
  • [3] The Therapeutic Efficacy of 177Lu-labeled Theranostic Polymeric Nanoparticles (177Lu-PNPs) in the Treatments of Head and Neck Cancer
    Hsieh, Hsin-Hua
    Chen, Chuan-Lin
    Wu, Chun-Yi
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [4] Optimized Therapeutic 177Lu-Labeled PSMA-Targeted Ligands with Improved Pharmacokinetic Characteristics for Prostate Cancer
    Wu, Yitian
    Zhang, Xiaojun
    Duan, Xiaojiang
    Yang, Xing
    Wang, Feng
    Zhang, Jinming
    PHARMACEUTICALS, 2022, 15 (12)
  • [5] Potentials of 177Lu-labeled sodium pyrophosphate (177Lu-PYP) as a new therapeutic radiopharmaceutical for the treatment of bone cancer
    Abbasi, Imtiaz Ahmed
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [6] 177Lu-Labeled Bivalent Ligands of Prostate-Specific Membrane Antigen for Endoradiotherapy of Prostate Cancer
    Dai, Ruoxue
    Cai, Zhikai
    Hu, Rui
    Huang, Yueqi
    Fu, Lilan
    Yang, Jiaqi
    Hu, Kongzhen
    Li, Hongsheng
    MOLECULAR PHARMACEUTICS, 2023, 21 (02) : 883 - 894
  • [7] 177Lu-labeled micro liposomes as a potential radiosynoviorthesis therapeutic agent
    Cvjetinovic, Borde
    Jankovic, Drina
    Milanovic, Zorana
    Mirkovic, Marija
    Petrovic, Jelena
    Prijovic, Zeljko
    Poghosyan, Emiliya
    Vranjes-Buric, Sanja
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 608
  • [8] 177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry
    Abouzayed, Ayman
    Seitova, Kamila
    Lundmark, Fanny
    Bodenko, Vitalina
    Oroujeni, Maryam
    Tolmachev, Vladimir
    Rosenstrom, Ulrika
    Orlova, Anna
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] 177Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer
    Du, Huan
    Hao, Xiaofei
    Lin, Binwei
    Tang, Mingming
    Wang, Decai
    Yang, Xia
    Wang, Jing
    Qin, Liling
    Yang, Yuchuan
    Du, Xiaobo
    JOURNAL OF NUCLEAR MEDICINE, 2025, 66 (03) : 377 - 384
  • [10] Streamlined Schemes for Dosimetry of 177Lu-Labeled PSMA Targeting Radioligands in Therapy of Prostate Cancer
    Kurth, Jens
    Heuschkel, Martin
    Tonn, Alexander
    Schildt, Anna
    Hakenberg, Oliver W.
    Krause, Bernd J.
    Schwarzenboeck, Sarah M.
    CANCERS, 2021, 13 (15)
12345